Skip to main content
Mar 13, 2023

Ruth Venning of Horizon Therapeutics on the regulatory changes IROs need to know

IR and ESG executive director talks 10K, cyber-security and climate disclosures
It’s fair to say the SEC is continuing to keep the financial community on its toes when it comes to revising, proposing and introducing new regulations. As the self-proclaimed ‘investor’s advocate’, the SEC’s areas of focus and scrutiny lately include the execution of retail orders, a review of crypto trading firms and amendments to ESG-related disclosures. With no slowing down of these wide-ranging regulatory overhauls in sight, Ruth Venning, executive director for investor relations and

To continue reading you need an active subscription

  • Quarterly issues of IR Magazine
  • Unlimited Articles online
  • Newsletter
  • Investor Perception Studies – Europe, US, Canada and Asia
  • Strategy guides
  • Whitepapers
  • Benchmarking reports
From $995*